Who to call at Lupin, and when
Fundz watches for the moments Lupin starts buying, and tells you who to reach.
- An alert the day Lupin raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Lupin, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Lupin. With Fundz connected, it knows.
Contract Type
partnership
Description
Lupin's subsidiary, VISUfarma, has inked an exclusive licensing agreement with Tenpoint Therapeutics for the commercialization of Yuvezzi, an eye drop treatment for presbyopia, across the European Union, U.K., and other regions. This partnership will enable VISUfarma to market and distribute Yuvezzi, while also involving strategic investments and potential milestone payments.
Quick answer
Lupin and Tenpoint Therapeutics Partner to Commercialize Yuvezzi in European Markets. (August 21, 2026).
- What agreement did Lupin announce on August 21, 2026?
- Lupin's subsidiary, VISUfarma, has inked an exclusive licensing agreement with Tenpoint Therapeutics for the commercialization of Yuvezzi, an eye drop treatment for presbyopia, across the European Union, U.K., and other regions. This partnership will enable VISUfarma to market and distribute Yuvezzi, while also involving strategic investments and potential milestone payments.
- What does Lupin do?
- Lupin is a Mumbai-based pharma major dedicated to advancing medical science and improving patient lives globally.
Source: Fundz verified event record.
Related People
Agreement Insights
What this usually meansLupin signed a new agreement. Fundz surfaces partnerships and contracts as they are announced.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.